FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
-23.69%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$486M
AUM Growth
+$486M
(-28%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
Olema Pharmaceuticals
OLMA
|
$9.43M |
| 2 |
Tempest Therapeutics
TPST
|
$2.75M |
| 3 |
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
|
$2.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $171M | 35.26% |
9,671,643
| – | – |
|
2
Lyell Immunopharma
LYEL
$221M
| $103M | 21.15% |
13,282,181
| – | – |
|
3
Aclaris Therapeutics
ACRS
$219M
| $49.4M | 10.17% |
3,399,034
| – | – |
|
4
Pharvaris
PHVS
$1.47B
| $46.9M | 9.66% |
3,261,926
| – | – |
|
5
Quantum-Si Incorporated
QSI
$215M
| $35.1M | 7.23% |
4,463,619
| – | – |
|
6
Nurix Therapeutics
NRIX
$716M
| $34.9M | 7.18% |
1,205,798
| – | – |
|
7
Kura Oncology
KURA
$717M
| $25.9M | 5.33% |
1,849,947
| – | – |
|
|
HLTH
8
DELISTED
Cue Health Inc. Common Stock
HLTH
| $13.5M | 2.78% |
1,006,089
| – | – |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| $6.04M | 1.24% |
1,787,094
| – | – |
|
|
10
Olema Pharmaceuticals
OLMA
$436M
| – | – |
-342,030
| Closed | -$9.43M |
|
|
11
Tempest Therapeutics
TPST
$45.7M
| – | – |
-190,213
| Closed | -$2.75M |
|
|
DBTX
12
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| – | – |
-297,711
| Closed | -$2.3M |
|